Form 4 for CLB Core Laboratories Inc. /DE/
Accepted 2023-10-03 00:00:00 ET · period of report 2023-10-01 · accession 0000950170-23-051344 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-03 | 2023-10-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | F - Tax | $24.01 | -270 | 6,095 | -4% | -$6,483 |
| D | 2023-10-03 | 2023-10-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | +700 | 6,365 | +12% | $0 |
| D | 2023-10-03 | 2023-10-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -700 | 4,530 | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-01 | F | D | 270 | $24.01 | 6,094.62 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-01 | M | A | 700 | $0.00 | 6,364.62 | D | — | — | |
| 3 | Derivative | Restricted Shares | 2023-10-01 | M | D | 700 | $0.00 | 4,530 | D | — · — to — | 700 Common Stock | (F2) Multiple restricted share grants are included in this total. (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. |